Predictive value of cerebroplacental ratio measured by Doppler ultrasound for neonatal outcomes in hypertensive disorders of pregnancy: a prospective observational study
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20252741Keywords:
NICU admission, Low birth weight, Hypertensive disorders of pregnancy, Fetal compromise, Cerebroplacental ratio, Doppler ultrasoundAbstract
Background: Hypertensive disorders of pregnancy (HDP) are among the most significant contributors to maternal and perinatal morbidity and mortality. Inadequate placental perfusion and foetal hypoxia are key mechanisms affecting fetal growth. The cerebroplacental ratio (CPR), derived from Doppler ultrasound of the middle cerebral artery (MCA) and umbilical artery (UA), is a non-invasive method to assess foetal well-being. This study evaluated the CPR as a predictive tool for adverse neonatal outcomes in HDP.
Methods: A prospective observational study was conducted at Saraswathi Institute of Medical Sciences, including 160 singleton pregnancies complicated by HDP beyond 32 weeks of gestation. All participants underwent Doppler velocimetry to assess CPR and were divided into group A (CPR≥1.0) and group B (CPR<1.0). Outcomes assessed included birth weight, Apgar score, NICU admission, and mode of delivery. Statistical analysis involved chi-square tests and sensitivity/specificity calculations.
Results: CPR<1.0 was significantly associated with higher caesarean section rates (80% versus 40%), low birth weight (<2500 gm in 67.5% versus 28.8%), low Apgar scores (<7 in 68.8% versus 25%), and increased NICU admissions (72.5% versus 28.8%). CPR showed high specificity but moderate sensitivity for predicting poor outcomes.
Conclusions: CPR is a valuable Doppler parameter that can aid in identifying foetuses at risk in hypertensive pregnancies, enabling timely intervention to improve perinatal outcomes.
Metrics
References
ACOG Practice Bulletin No. 222: Gestational Hypertension and Preeclampsia. Obstet Gynecol. 2020;135(6):e237-60. DOI: https://doi.org/10.1097/AOG.0000000000003891
Sukphadung K, Petchud A, Prommas S, Smanchat B. The predictive value of cerebroplacental ratio in hypertensive disorders of pregnancy. Thai J Obstet Gynaecol. 2018;26(3):157-64.
Arduini D, Rizzo G. Prediction of fetal outcome in SGA fetuses: Doppler measurements of fetal vessels. J Perinat Med. 1992;20(1):29-38. DOI: https://doi.org/10.1515/jpme.1992.20.1.29
Baschat AA. Doppler application in the delivery timing of the preterm growth-restricted fetus. Ultrasound Obstet Gynecol. 2004;23(2):111-8. DOI: https://doi.org/10.1002/uog.989
Figueras F, Gratacós E. Update on the diagnosis and classification of fetal growth restriction. Fetal Diagn Ther. 2014;36(2):86-98.
Khalil A, Morales-Roselló J, Townsend R, Baschat A, Prefumo F, Hecher K, et al. Third-trimester cerebroplacental ratio in predicting adverse perinatal outcome: a meta-analysis. Ultrasound Obstet Gynecol. 2017;49(5):559-65.
Vyas S, Nicolaides KH, Campbell S, Griffin D, Rodeck CH. MCA flow in fetal hypoxemia. BJOG. 1990;97(9):797-803. DOI: https://doi.org/10.1111/j.1471-0528.1990.tb02573.x
Grivell RM, Wong L, Bhatia V, Kaitu'u-Lino T, Tong S, Wallace EM, et al. Cerebroplacental ratio in high-risk pregnancies: a systematic review. Am J Obstet Gynecol. 2015;213(1):40.e1-13.
Axt-Fliedner R, Schwarze A, Nelle M, Altgassen C, Friedrich M, Schmidt W, et al. Doppler sonography in high-risk pregnancies. Arch Gynecol Obstet. 2005;271(3):144-9. DOI: https://doi.org/10.1007/s00404-004-0648-4
Lees C, Marlow N, Arabin B, Bilardo CM, Brezinka C, Derks JB, et al. Perinatal outcome in early-onset FGR: TRUFFLE study. Lancet. 2015;385(9983):2162-72. DOI: https://doi.org/10.1016/S0140-6736(14)62049-3
Odibo AO, Goetzinger KR, Cahill AG, Macones GA, Nelson D, Magner K, et al. Third-trimester Doppler and preeclampsia outcomes. Am J Obstet Gynecol. 2012;206(6):558.e1-8. DOI: https://doi.org/10.1016/j.ajog.2011.10.035
Patil V, Gowda S, Das S, Rani R. Role of cerebroplacental ratio in prediction of adverse perinatal outcome. Int J Reprod Contracept Obstet Gynecol. 2019;8(3):871-7.
Saxena U. Cerebroplacental ratio in hypertensive pregnancies: prediction of perinatal outcome. Int J Reprod Contracept Obstet Gynecol. 2021;10(1):45-9.
Unterscheider J, Daly S, Geary MP, Malone FD, Morrison JJ, Higgins JR, et al. Delivery timing in FGR. Obstet Gynecol. 2013;122(5):973-8.
Mari G, Deter RL, Carpenter RL, Rahman F, Zimmerman R, Moise KJ, et al. Noninvasive diagnosis by Doppler ultrasonography of fetal anemia. N Engl J Med. 2000;342(1):9-14. DOI: https://doi.org/10.1056/NEJM200001063420102
Romero R, Pilu G, Jeanty P, Ghidini A, Hobbins JC. Prenatal diagnosis of congenital anomalies. McGraw-Hill; 2003.
Hofstaetter C, Dubiel M, Gudmundsson S. Doppler in high-risk pregnancy. Ultrasound Obstet Gynecol. 2002;19(3):252-6.
Tongsong T, Boonyanurak P. MCA velocity in fetal anemia. J Ultrasound Med. 2005;24(6):697-702. DOI: https://doi.org/10.7863/jum.2005.24.5.697
Mandruzzato G, Antsaklis A, Botet F, Chervenak FA, Figueras F, Grunebaum A, et al. IUGR: diagnosis and management. J Perinat Med. 2008;36(4):277-81. DOI: https://doi.org/10.1515/JPM.2008.050
Figueras F, Gratacós E. Fetal growth restriction management protocol. Fetal Diagn Ther. 2014;36(2):86-98. DOI: https://doi.org/10.1159/000357592